Header Logo

Connection

Cynthia Campbell to Cohort Studies

Back to Details
This is a "connection" page, showing publications Cynthia Campbell has written about Cohort Studies.
Cynthia Campbell
Connection Strength
0.773
Cohort Studies
  1. Clinical Use of Mental Health Digital Therapeutics in a Large Health Care Delivery System: Retrospective Patient Cohort Study and Provider Survey. JMIR Ment Health. 2024 Oct 02; 11:e56574.
    View in: PubMed
    Score: 0.152
  2. Overall and Telehealth Addiction Treatment Utilization by Age, Race, Ethnicity, and Socioeconomic Status in California After COVID-19 Policy Changes. JAMA Health Forum. 2023 05 05; 4(5):e231018.
    View in: PubMed
    Score: 0.138
  3. The role of substance use disorders in experiencing a repeat opioid overdose, and substance use treatment patterns among patients with a non-fatal opioid overdose. Drug Alcohol Depend. 2020 04 01; 209:107923.
    View in: PubMed
    Score: 0.110
  4. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175.
    View in: PubMed
    Score: 0.092
  5. Prevalence and trends of suspected cannabinoid hyperemesis syndrome over an 11-year period in Northern California: An electronic health record study. Drug Alcohol Depend. 2024 Oct 01; 263:112418.
    View in: PubMed
    Score: 0.038
  6. Opioid Administration Practice Patterns in Patients With Acute Respiratory Failure Who Undergo Invasive Mechanical Ventilation. Crit Care Explor. 2024 Jul 01; 6(7):e1123.
    View in: PubMed
    Score: 0.037
  7. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis. 2012 Apr; 54(7):1026-34.
    View in: PubMed
    Score: 0.032
  8. Prevalence and treatment of opioid use disorders among primary care patients in six health systems. Drug Alcohol Depend. 2020 02 01; 207:107732.
    View in: PubMed
    Score: 0.027
  9. Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med. 2009 Sep; 24(9):1065-72.
    View in: PubMed
    Score: 0.026
  10. Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. J Pain Symptom Manage. 2009 Aug; 38(2):197-207.
    View in: PubMed
    Score: 0.026
  11. Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection. Ann Intern Med. 2009 Mar 03; 150(5):301-13.
    View in: PubMed
    Score: 0.026
  12. Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. Clin Vaccine Immunol. 2006 Apr; 13(4):511-9.
    View in: PubMed
    Score: 0.021
  13. Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study. Clin Infect Dis. 2004 Sep 01; 39(5):717-24.
    View in: PubMed
    Score: 0.019
  14. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011 Dec; 20(12):2551-9.
    View in: PubMed
    Score: 0.016
  15. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92.
    View in: PubMed
    Score: 0.014

© 2025 Kaiser Permanente